Neoplasia

Article	Citations
Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes	1100
Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada	91
Enhanced Apc adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells	58
Tumor marker-based RecistTM is superior to RECIST as criteria to predict the long-term benefits of targeted therapy in advanced non-small-cell lung cancer with driver gene mutations	58
Interdisciplinary care of children with diffuse midline glioma	55
Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment	48
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene	43
The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms	41
Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances.	38
Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision	36
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma	34
Myeloid-derived suppressor cells promote tumor growth and sorafenib resistance by inducing FGF1 upregulation and fibrosis	33
Cyst fluid metabolites distinguish malignant from benign pancreatic cysts	33
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells	33
The breast tissue microbiome, stroma, immune cells and breast cancer	30
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas	29
mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer	29
Therapeutic effiacy of T cells expressing chimeric antigen receptor derived from a mesothelin-specific scFv in orthotopic human pancreatic cancer animal models	29
In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer	28
Combined BRAF and PIM1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of PIM1: Synergistic effect and metabolic mechanisms	27
Trop‐2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis	27
Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer	26
Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair	25
Combining selinexor with alisertib to target the p53 pathway in neuroblastoma	25
Current state of pediatric neuro-oncology imaging, challenges and future directions	25

TPM4 overexpression drives colon epithelial cell tumorigenesis by suppressing differentiation and promoting proliferation	24
Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents	24
Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis	24
Past, present and future of Focused Ultrasound as an adjunct or complement to DIPG/DMG therapy: A consensus of the 2021 FUSF DIPG meeting	23
Noninvasive optoacoustic microangiography reveals dose and size dependency of radiation-induced deep tumor vasculature remodeling	23
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD	23
Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways	22
Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors	22
Epitranscriptomic mechanisms of androgen signalling and prostate cancer	22
PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structures	21
Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats	21
ARID1A loss sensitizes colorectal cancer cells to floxuridine	21
Impact of tissue penetration and albumin binding on design of T cell targeted bispecific agents	21
Targeting hypoxia regulated sodium driven bicarbonate transporters reduces triple negative breast cancer metastasis	20
Rosmarinic acid represses colitis-associated colon cancer: A pivotal involvement of the TLR4-mediated NF-κB-STAT3 axis	20
On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitro	20
Bacterial translocation and barrier dysfunction enhance colonic tumorigenesis	20
Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation	20
ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells	20
Early growth response-1 is a new substrate of the GSK3β-FBXW7 axis	20
Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression	20
Genomics driven precision oncology in advanced biliary tract cancer improves survival	19
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era	19
Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC	19
KCTD1 is a new modulator of the KCASH family of Hedgehog suppressors	18
Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-XL dual inhibitor that induces Bax-dependent apoptosis	17
Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan	17
Hsa_circ_0001583 fuels bladder cancer metastasis by promoting staphylococcal nuclease and tudor domain containing 1-mediated MicroRNA decay	17
Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]	16
Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance	16
SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway	15
Corrigendum to “NFAT1 hypermethylation promotes epithelial‐mesenchymal transition and metastasis in nasopharyngeal carcinoma by activating ITGA6 transcription” [Neoplasia 21 (2019): 311–321]	15
Corrigendum to ‘Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment’ Neoplasia, Volume 22, Issue 2 (2020) 111–119	15
Corrigendum to “Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment” [Neoplasia, Volume 22, Issue 2 (2020) 111–119]	15
Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]	15
Transcriptomic and proteomic profiling identifies feline fibrosarcoma as clinically amenable model for aggressive sarcoma subtypes	14
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma	14
Microbial molecules, metabolites, and malignancy	14
High p16INK4A expression in glioblastoma is associated with senescence phenotype and better prognosis	14
Corrigendum to “Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells” [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549–562]	14
GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer	13
The paradox of radiation and T cells in tumors	13
Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing	13
Extracellular signals induce dynamic ER remodeling through αTAT1-dependent microtubule acetylation	13
Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue	13
Prognostic value of integrin αV expression and localization pattern in invasive breast carcinomas	13
TCF7L2 silencing results in altered gene expression patterns accompanied by local genomic reorganization	13
Informatics strategies for early detection and risk mitigation in pancreatic cancer patients	13
Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma	13
WDR68 stimulates cellular proliferation via activating ribosome biogenesis in 293T cells	13

A combinatorial drug screen in PDX-derived primary rhabdomyosarcoma cells identifies the NOXA - BCL-XL/MCL-1 balance as target for re-sensitization to first-line therapy in recurrent tumors	13
The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma	12
Mutational signatures and their association with survival and gene expression in urological carcinomas	12
Nucleostemin upregulation and STAT3 activation as early events in oral epithelial dysplasia progression to squamous cell carcinoma	12
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma	12
ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma	12
Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy	12
Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma	11
Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients – Knowledge from two independent internation	11
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer	11
Targeting IL-23 for the interception of obesity-associated colorectal cancer	11
Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategies	11
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy	11
CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation	11
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas	11
Retrospective dataset and survey analyses identify gaps in data collection for craniopharyngioma and priorities of patients and families affected by the disease	11
ALK inhibitors downregulate the expression of death receptor 4 in ALK-mutant lung cancer cells via facilitating Fra-1 and c-Jun degradation and subsequent AP-1 suppression	11
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice	11
Comparison of adjuvant gemcitabine plus S-1 with S-1 monotherapy for pancreatic ductal adenocarcinoma: Retrospective real-world data	11
Disease burden and projection of total and early-onset colorectal cancer in Gulf cooperation council countries from 1990 to 2019	10
FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma	10
Heterogeneous expression of predictive biomarkers PD-L1 and TIGIT in non-mucinous lung adenocarcinoma and corresponding lymph node metastasis: A challenge for clinical biomarker testing	10
Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancer	10
Microbial mechanisms to improve immune checkpoint blockade responsiveness	10
Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40	10
Nuclear morphology predicts cell survival to cisplatin chemotherapy	10
Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinoma	10
Microbiota-driven mechanisms at different stages of cancer development	9
Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer	9
Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis	9
LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44	9
mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics	9
Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer	9
PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1	9
Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma	9
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy	9
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology	9
Role of heparanase 2 (Hpa2) in gastric cancer	9
Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization	9
Probing the glioma micro-environment: Analysis using biopsy in combination with ultra-fast cyclic immunolabeling	9
Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery	9
Tumor-Infiltrating Immune Cells in Colorectal Cancer	8
Corrigendum to “ErbB3 ligand, Heregulin1, is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation” [Neoplasia 21 (2019) 343–352]	8
Optimal radiation dose to induce an abscopal effect by combining carbon-ion radiotherapy and anti-CTLA4 antibody	8
Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system	8
Glycolysis-induced drug resistance in tumors—A response to danger signals?	8
PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A	8
Corrigendum to “Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL” [Neoplasia. Vol. 9, No. 5, May 2007, pp. 435–442]	8
Understanding the roles of N6-methyladenosine writers, readers and erasers in breast cancer	8
The Abl/Abi signaling links WAVE regulatory complex to Cbl E3 ubiquitin ligase and is essential for breast cancer cell metastasis	8
Targeted immune cell therapy for hepatocellular carcinoma using expanded liver mononuclear cell-derived natural killer cells	8
Depletion of regulatory T cells enhances the T cell response induced by the neoantigen vaccine with weak immunogenicity	8
Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series	8
RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer	8
A sensitive and robust plasma-based DNA methylation panel for early detection of target gastrointestinal cancers	7
Retraction notice to “Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors” [Neoplasia 18 (2016) 347- 355/201]	7
Depletion of β1,6-N-acetylglucosaminyltransferase reduces E-selectin binding capacity and migratory potential of human gastrointestinal adenocarcinoma cells	7
Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation	7
Sequential treatment of anti-PD-L1 therapy prior to anti-VEGFR2 therapy contributes to more significant clinical benefits in non-small cell lung cancer	7
Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization	7
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer	7
Stabilization of the classical phenotype upon integration of pancreatic cancer cells into the duodenal epithelium	7
Suppression of ER-stress induction of GRP78 as an anti-neoplastic mechanism of the cardiac glycoside Lanatoside C in pancreatic cancer	7
Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium	7
Corrigendum to “Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells” [Neoplasia 39 (2023), 100893]	7
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism	7
Lactate promoted cisplatin resistance in NSCLC by modulating the m6A modification-mediated FOXO3/MAGI1-IT1/miR-664b-3p/IL-6R axis	7
Therapeutic significance of ARID1A mutation in bladder cancer	7
Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors	7
SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy	6
A synergistic approach for modulating the tumor microenvironment to enhance nano-immunotherapy in sarcomas	6
Lysyl hydroxylase 2-induced collagen cross-link switching promotes metastasis in head and neck squamous cell carcinomas	6
Engineering and characterization of Hu3A4: A novel humanized antibody with potential as a therapeutic agent against myeloid lineage leukemias	6
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition	6
DNA polymerase β deficiency promotes the occurrence of esophageal precancerous lesions in mice	6
Altered endosomal-lysosomal biogenesis in melanoma	6
A mutual information-based in vivo monitoring of adaptive response to targeted therapies in melanoma	6
A deep learning based holistic diagnosis system for immunohistochemistry interpretation and molecular subtyping	6
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients	6
FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer	6

Suppression of tumor progression by thioredoxin-interacting protein-dependent adenosine 2B receptor degradation in a PLAG-treated Lewis lung carcinoma-1 model of non–small cell lung cancer	6
Cell communication pathway prognostic model identified detrimental neurodevelopmental pathways in neuroblastoma	6
Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production	6
Proprotein convertase subtilisin/kexin Type 9 is required for Ahnak-mediated metastasis of melanoma into lung epithelial cells	6
P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9	6
Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT3	6
Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics	5
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study	5
Distinction of papillary and adamantinomatous craniopharyngioma: Clinical features, surgical nuances and hypothalamic outcomes	5
Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin	5
Druggable gene alterations in Japanese patients with rare malignancy	5
Strength and duration of GIPC-dependent signaling networks as determinants in cancer	5
Oncogene-independent resistance in Philadelphia chromosome - positive (Ph+) acute lymphoblastic leukemia (ALL) is mediated by activation of AKT/mTOR pathway	5
NEDD9 is transcriptionally regulated by HDAC4 and promotes breast cancer metastasis and macrophage M2 polarization via the FAK/NF-κB signaling pathway	5
Clinical and genetic profile of Chinese patients with indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract	5
Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis	5
Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia	5
Reduction in mitochondrial oxidative stress mediates hypoxia-induced resistance to cisplatin in human transitional cell carcinoma cells	5
PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway	5
HDAC6 promotes aggressive development of liver cancer by improving egfr mRNA stability	5
Targeting Na-H exchanger 1 overcomes nuclear factor kappa B-mediated tumor resistance to radiotherapy	5
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications	4
Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases	4
A new, simplified endoscopic scoring system for predicting clinical outcome in gastric low-grade intraepithelial neoplasia: the “e-cout system”	4
Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations	4
DNA methylation landscape reveals GNAS as a decitabine-responsive marker in patients with acute myeloid leukemia	4
Systematic analysis of human colorectal cancer scRNA-seq revealed limited pro-tumoral IL-17 production potential in gamma delta T cells	4
Insights into the metastatic bone marrow niche gained from fibronectin and β1 integrin transgenic mice	4
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations	4
Enterococcus faecalis promotes a migratory and invasive phenotype in colon cancer cells	4
Characteristics and survival of primary urothelial carcinoma of the prostate: A multi-center retrospective study of 18 cases	4
Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing	4
Corrigendum to “NF-κB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIα Protein” [Neoplasia 19 (2017) 672–683]	4
STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway	4
MLH1 mediates cytoprotective nucleophagy to resist 5-Fluorouracil-induced cell death in colorectal carcinoma	4
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization	4
Identification of disease-promoting stromal components by comparative proteomic and transcriptomic profiling of canine mammary tumors using laser-capture microdissected FFPE tissue	4
Optical scattering as an early marker of apoptosis during chemotherapy and antiangiogenic therapy in murine models of prostate and breast cancer	4
Glypican-1-targeted antibody–drug conjugate inhibits the growth of glypican-1-positive glioblastoma	4
The renal clear cell carcinoma immune landscape	4
Epigenetic DNA modifications and vitamin C in prostate cancer and benign prostatic hyperplasia: Exploring similarities, disparities, and pathogenic implications	4
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities	4
The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia	3
ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma	3
Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer	3
Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity	3
Therapeutic targeting of tumor spheroids in a 3D microphysiological renal cell carcinoma-on-a-chip system	3
Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cells	3
Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia	3
Leptomeningeal dissemination in pediatric brain tumors	3
Targeting GRP78 suppresses oncogenic KRAS protein expression and reduces viability of cancer cells bearing various KRAS mutations	3
Challenges in synergizing radiotherapy with immunotherapy to unlock the abscopal effect in metastatic NSCLC: A systematic review	3
Influence of alectinib and crizotinib on ionizing radiation - in vitro analysis of ALK/ROS1-wildtype lung tissue cells	3
Advancing glioblastoma treatment by targeting metabolism	3
p53/FBXL20 axis negatively regulates the protein stability of PR55α, a regulatory subunit of PP2A Ser/Thr phosphatase	3
ST6GAL1 is associated with poor response to chemoradiation in rectal cancer	3
Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model	3
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science	3
RosettaSX: Reliable gene expression signature scoring of cancer models and patients	3
Corrigendum to “Depletion of ß1,6-N-acetylglucosaminyltransferase reduces E-selectin binding capacity and migratory potential of human gastrointestinal adenocarcinoma cells” [Neoplasia 59 (2024) 10183	3
Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma	3
Analysis of RANK-c interaction partners identifies TRAF3 as a critical regulator of breast cancer aggressiveness	3
Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients’ bone marrow	3
The Influence of the microbiome on the innate immune microenvironment of solid tumors	3
Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin pathway	3
Inhibition of fibronectin accumulation suppresses tumor growth	3
Global, regional, and national burden of very early-onset colorectal cancer and its risk factors from 1990 to 2019: A systematic analysis for the global burden of disease study 2019	3
Advanced progress of spatial metabolomics in head and neck cancer research	3
Global molecular alterations involving recurrence or progression of pediatric brain tumors	2
Image-based deep learning model using DNA methylation data predicts the origin of cancer of unknown primary	2
Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus	2
Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice	2
Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma	2
DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway	2
A systematic review of microbiome-derived biomarkers for early colorectal cancer detection	2
Tumor necrosis factor receptor signaling modulates carcinogenesis in a mouse model of breast cancer	2
PI3K-CCL2-CCR2-MDSCs axis: A potential pathway for tumor Clostridia-promoted CD 8+ T lymphocyte infiltration in bile tract cancers	2
Myeloperoxidase exerts anti-tumor activity in glioma after radiotherapy	2
STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma	2
Evidence based on Mendelian randomization: Causal relationship between mitochondrial biological function and lung cancer and its subtypes	2
Two transition states of the glycogen shunt and two steady states of gene expression support metabolic flexibility and the Warburg effect in cancer	2
Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin	2
Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation	2
Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice	2
Aurkin-A, a TPX2-Aurora A small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma	2
Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis	2
A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma	2
Checkpoint inhibitor responses can be regulated by the gut microbiota – A systematic review	2
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR	2
Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway	2
Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma	2
A novel regulatory axis of MSI2-AGO2/miR-30a-3p-CGRRF1 drives cancer chemoresistance by upregulating the KRAS/ERK pathway	2
Primary central nervous system germ cell tumors in children and young adults: A review of controversies in diagnostic and treatment approach	2
Epstein-Barr virus deubiquitinating enzyme BPLF1 is involved in EBV carcinogenesis by affecting cellular genomic stability	2
Spatial distribution of immune checkpoint proteins in histological subtypes of lung adenocarcinoma	2